US Patent Issued to GRIFFITH UNIVERSITY on Aug. 12 for "Immunogenic peptide against group a Streptococcus" (Australian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,630, issued on Aug. 12, was assigned to GRIFFITH UNIVERSITY (Nathan, Australia).

"Immunogenic peptide against group a Streptococcus" was invented by Michael F. Good (The Gap, Australia), Manisha Pandey (Calamvale, Australia) and Michael Raymond Batzloff (Holmview, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A modified p145 peptide having enhanced mucosal immunogenicity for use in eliciting a mucosal immune response to group A streptococcal bacteria in a mammal such as a human. Intramuscular administration of the modified p145 peptide may be particularly efficacious. An S2 peptide or variant may be co-administered with the modified p145 ...